The traditional complications of diabetes mellitus are well known and continue to pose a
considerable burden on millions of people living with diabetes mellitus. However, advances …

Diabetes is a complex metabolic disorder affecting the glucose status of the human body.
Chronic hyperglycaemia related to diabetes is associated with end organ failure. The clinical …

Background Environmental and lifestyle changes, in addition to the ageing of populations,
are generally believed to account for the rapid global increase in type 2 diabetes prevalence …

Цель. Оценка распространенности сахарного диабета 2 типа (СД2) у взрослого
населения России. Методы. NATION это первое национальное эпидемиологическое …

Diabetes mellitus is a complex metabolic disorder associated with an increased risk of
microvascular and macrovascular disease; its main clinical characteristic is hyperglycaemia …

Obesity is one of the main risk factors for type 2 diabetes (T2D), representing a major
worldwide health crisis. Modest weight-loss (≥ 5% but< 10%) can minimize and reduce …

Prevalence of type 2 diabetes (T2D) and obesity is increasing worldwide. Currently
available therapies are not suited for all patients in the heterogeneous obese/T2D …

Background Empagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor that has
demonstrated cardiovascular and renal protection in patients with type 2 diabetes (T2D). We …

Diabetes mellitus is a serious disease affecting about 5% of people worldwide. Diabetes is
characterized by hyperglycemia and impairment in insulin secretion and/or action …

Type 2 diabetes mellitus (T2DM) is a complex metabolic disorder with various contributing
factors including genetics, epigenetics, environment and lifestyle such as diet. The hallmarks …